Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HCA Healthcare (HCA)

HCA Inc. completes $5.25 billion senior notes offering maturing 2028 to 2055

Neutral Impact 3 of 5 financing Written later

HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a public offering of $5.25 billion in senior notes on February 21, 2025, across six tranches maturing between 2028 and 2055. The notes are guaranteed on a senior unsecured basis by HCA Healthcare, and the filing adds $5.25 billion of direct financial obligations to the company's debt.

Key points

  • Six tranches total $5.25 billion: $700 million 5.000% notes due 2028, $300 million floating rate notes due 2028, $750 million 5.250% notes due 2030, $750 million 5.500% notes due 2032, $1.5 billion 5.750% notes due 2035 and $1.25 billion 6.
  • Interest on the fixed-rate notes is payable semi-annually on March 1 and September 1, starting September 1, 2025
  • The notes were sold under a shelf registration filed May 1, 2023, with underwriters including BofA Securities, Barclays and J.P. Morgan, under an underwriting agreement dated February 18, 2025

The filing

CompanyHCA Healthcare (HCA)
Form8-K, current report
Filed with the SECFeb 21, 2025, 4:10 PM ET
Accession number0001193125-25-031999

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 21, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.